Cardiac Biotech Solutions, Inc. (CBSC)
0.0399
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
Cardiac Biotech Solutions Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.1596M |
| September 30, 2025 | 0.1548M |
| June 30, 2025 | 0.1863M |
| March 31, 2025 | 0.1732M |
| December 31, 2024 | |
| September 30, 2024 |
| Date | Value |
|---|---|
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | 0.485M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vyome Holdings, Inc. | 1.591M |
| Abbott Laboratories | 3.128B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.69M |
| AtriCure, Inc. | 94.05M |